Latest stories on AKTS
Aktis Oncology: Mini-Proteins With A Targeted Punch
Seeking Alpha58 · neutralproduct/pr
Aktis Oncology to Present at the Jefferies Global Healthcare Conference | AKTS Stock News
StockTitan50 · neutralgeneral
AKTIS ONCOLOGY INC (AKTS) news roundup. 1 story in the last 24 hours, 1 in the past week, 3 over 30 days. Average 24-hour sentiment is 58/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.